These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33248414)

  • 1. A label-free microfluidic chip for the highly selective isolation of single and cluster CTCs from breast cancer patients.
    Zhang X; Lu X; Gao W; Wang Y; Jia C; Cong H
    Transl Oncol; 2021 Jan; 14(1):100959. PubMed ID: 33248414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
    Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?
    Rahmanian M; Sartipzadeh Hematabad O; Askari E; Shokati F; Bakhshi A; Moghadam S; Olfatbakhsh A; Al Sadat Hashemi E; Khorsand Ahmadi M; Morteza Naghib S; Sinha N; Tel J; Eslami Amirabadi H; den Toonder JMJ; Majidzadeh-A K
    J Adv Res; 2023 May; 47():105-121. PubMed ID: 35964874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of circulating tumor cells from lung cancer patients using microfluidic chip.
    Qian C; Wu S; Chen H; Zhang X; Jing R; Shen L; Wang X; Ju S; Jia C; Cong H
    Clin Exp Med; 2018 May; 18(2):191-202. PubMed ID: 29445889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
    Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
    J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
    Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
    Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
    Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
    Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous on-chip isolation and characterization of circulating tumor cell sub-populations.
    Lee J; Kwak B
    Biosens Bioelectron; 2020 Nov; 168():112564. PubMed ID: 32892118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
    Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
    Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multistage microfluidic cell sorting method and chip based on size and stiffness.
    Li G; Ji Y; Wu Y; Liu Y; Li H; Wang Y; Chi M; Sun H; Zhu H
    Biosens Bioelectron; 2023 Oct; 237():115451. PubMed ID: 37327603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients.
    Hyun KA; Kwon K; Han H; Kim SI; Jung HI
    Biosens Bioelectron; 2013 Feb; 40(1):206-12. PubMed ID: 22857995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
    Zeinali M; Lee M; Nadhan A; Mathur A; Hedman C; Lin E; Harouaka R; Wicha MS; Zhao L; Palanisamy N; Hafner M; Reddy R; Kalemkerian GP; Schneider BJ; Hassan KA; Ramnath N; Nagrath S
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
    Vetter M; Landin J; Szczerba BM; Castro-Giner F; Gkountela S; Donato C; Krol I; Scherrer R; Balmelli C; Malinovska A; Zippelius A; Kurzeder C; Heinzelmann-Schwarz V; Weber WP; Rochlitz C; Aceto N
    Breast Cancer Res; 2018 Nov; 20(1):141. PubMed ID: 30458879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-cocktail Functionalized Nano-microfluidic Chip for Enhancing Isolation and Characterization of Circulating Cancer Cells.
    Li M; Liu D; Zhang J; Zhang X; Dou X
    Anticancer Res; 2022 Sep; 42(9):4345-4358. PubMed ID: 36039433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the polymeric circulating tumor cell chip to capture circulating tumor cells in blood samples of patients with colorectal cancer.
    Kure K; Hosoya M; Ueyama T; Fukaya M; Sugimoto K; Tomiki Y; Ohnaga T; Sakamoto K; Komiyama H
    Oncol Lett; 2020 Mar; 19(3):2286-2294. PubMed ID: 32194728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
    Aktas B; Kasimir-Bauer S; Müller V; Janni W; Fehm T; Wallwiener D; Pantel K; Tewes M;
    BMC Cancer; 2016 Jul; 16():522. PubMed ID: 27456970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.